Urinary Tract Infections Due to Candida albicans

John Fremont Fisher, William H. Chew, Smith Shadomy, Richard J. Duma, C. Glen Mayhan, William C. House

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Infection of the urinary tract due to Candida albicans is an uncommon but well-described complication of modern therapeutics. Despite the rarity of this infection, culture of properly collected urine yielding C. albicans requires an explanation. The significance of systemic factors in the defense of the urinary tract against candidal infection is unknown, but secretions from the prostate gland in men and from periurethral glands in women have been reported to be fungistatic. In addition, growth of Candida at sites on mucous membranes may be suppressed by other normal flora. Conditions that predispose to candiduria include diabetes mellitus, antibiotic and corticosteroid therapy, as well as factors such as local physiology and disturbance of urine flow. Lower urinary tract candidiasis is usually the result of a retrograde infection, while renal parenchymal infection most often follows candidemia. In addition to asymptomatic candiduria, recognized clinical forms of candidal urinary tract infections include bladder infection, renal parenchymal infection, and infections associated with fungus ball formation. Unfortunately, clinical criteria alone are insufficient to distinguish reliably among these clinical types. If the urine is found to contain candidal organisms, the condition of the patient should be considered for determination of appropriate therapy. When infection is thought to be confined to the bladder, patients without indwelling bladder catheters should be considered for flucytosine therapy. For patients requiring indwelling bladder catheterization, irrigation with amphotericin B is usually successful. Although flucytosine alone may be useful for renal parenchymal candidal infection, iv amphotericin B alone or the combination of amphotericin B and flucytosine is indicated when systemic candidiasis cannot be excluded.

Original languageEnglish (US)
Pages (from-to)1107-1118
Number of pages12
JournalReviews of Infectious Diseases
Volume4
Issue number6
DOIs
StatePublished - Jan 1 1982

Fingerprint

Candida albicans
Urinary Tract Infections
Infection
Flucytosine
Urinary Bladder
Amphotericin B
Urine
Urinary Tract
Kidney
Candidemia
Indwelling Catheters
Candidiasis
Therapeutics
Candida
Catheterization
Prostate
Diabetes Mellitus
Adrenal Cortex Hormones
Mucous Membrane
Fungi

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Fisher, J. F., Chew, W. H., Shadomy, S., Duma, R. J., Mayhan, C. G., & House, W. C. (1982). Urinary Tract Infections Due to Candida albicans. Reviews of Infectious Diseases, 4(6), 1107-1118. https://doi.org/10.1093/clinids/4.6.1107

Urinary Tract Infections Due to Candida albicans. / Fisher, John Fremont; Chew, William H.; Shadomy, Smith; Duma, Richard J.; Mayhan, C. Glen; House, William C.

In: Reviews of Infectious Diseases, Vol. 4, No. 6, 01.01.1982, p. 1107-1118.

Research output: Contribution to journalArticle

Fisher, JF, Chew, WH, Shadomy, S, Duma, RJ, Mayhan, CG & House, WC 1982, 'Urinary Tract Infections Due to Candida albicans', Reviews of Infectious Diseases, vol. 4, no. 6, pp. 1107-1118. https://doi.org/10.1093/clinids/4.6.1107
Fisher, John Fremont ; Chew, William H. ; Shadomy, Smith ; Duma, Richard J. ; Mayhan, C. Glen ; House, William C. / Urinary Tract Infections Due to Candida albicans. In: Reviews of Infectious Diseases. 1982 ; Vol. 4, No. 6. pp. 1107-1118.
@article{5df6b38e54934dea94c132ba58e54bbb,
title = "Urinary Tract Infections Due to Candida albicans",
abstract = "Infection of the urinary tract due to Candida albicans is an uncommon but well-described complication of modern therapeutics. Despite the rarity of this infection, culture of properly collected urine yielding C. albicans requires an explanation. The significance of systemic factors in the defense of the urinary tract against candidal infection is unknown, but secretions from the prostate gland in men and from periurethral glands in women have been reported to be fungistatic. In addition, growth of Candida at sites on mucous membranes may be suppressed by other normal flora. Conditions that predispose to candiduria include diabetes mellitus, antibiotic and corticosteroid therapy, as well as factors such as local physiology and disturbance of urine flow. Lower urinary tract candidiasis is usually the result of a retrograde infection, while renal parenchymal infection most often follows candidemia. In addition to asymptomatic candiduria, recognized clinical forms of candidal urinary tract infections include bladder infection, renal parenchymal infection, and infections associated with fungus ball formation. Unfortunately, clinical criteria alone are insufficient to distinguish reliably among these clinical types. If the urine is found to contain candidal organisms, the condition of the patient should be considered for determination of appropriate therapy. When infection is thought to be confined to the bladder, patients without indwelling bladder catheters should be considered for flucytosine therapy. For patients requiring indwelling bladder catheterization, irrigation with amphotericin B is usually successful. Although flucytosine alone may be useful for renal parenchymal candidal infection, iv amphotericin B alone or the combination of amphotericin B and flucytosine is indicated when systemic candidiasis cannot be excluded.",
author = "Fisher, {John Fremont} and Chew, {William H.} and Smith Shadomy and Duma, {Richard J.} and Mayhan, {C. Glen} and House, {William C.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1093/clinids/4.6.1107",
language = "English (US)",
volume = "4",
pages = "1107--1118",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Urinary Tract Infections Due to Candida albicans

AU - Fisher, John Fremont

AU - Chew, William H.

AU - Shadomy, Smith

AU - Duma, Richard J.

AU - Mayhan, C. Glen

AU - House, William C.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Infection of the urinary tract due to Candida albicans is an uncommon but well-described complication of modern therapeutics. Despite the rarity of this infection, culture of properly collected urine yielding C. albicans requires an explanation. The significance of systemic factors in the defense of the urinary tract against candidal infection is unknown, but secretions from the prostate gland in men and from periurethral glands in women have been reported to be fungistatic. In addition, growth of Candida at sites on mucous membranes may be suppressed by other normal flora. Conditions that predispose to candiduria include diabetes mellitus, antibiotic and corticosteroid therapy, as well as factors such as local physiology and disturbance of urine flow. Lower urinary tract candidiasis is usually the result of a retrograde infection, while renal parenchymal infection most often follows candidemia. In addition to asymptomatic candiduria, recognized clinical forms of candidal urinary tract infections include bladder infection, renal parenchymal infection, and infections associated with fungus ball formation. Unfortunately, clinical criteria alone are insufficient to distinguish reliably among these clinical types. If the urine is found to contain candidal organisms, the condition of the patient should be considered for determination of appropriate therapy. When infection is thought to be confined to the bladder, patients without indwelling bladder catheters should be considered for flucytosine therapy. For patients requiring indwelling bladder catheterization, irrigation with amphotericin B is usually successful. Although flucytosine alone may be useful for renal parenchymal candidal infection, iv amphotericin B alone or the combination of amphotericin B and flucytosine is indicated when systemic candidiasis cannot be excluded.

AB - Infection of the urinary tract due to Candida albicans is an uncommon but well-described complication of modern therapeutics. Despite the rarity of this infection, culture of properly collected urine yielding C. albicans requires an explanation. The significance of systemic factors in the defense of the urinary tract against candidal infection is unknown, but secretions from the prostate gland in men and from periurethral glands in women have been reported to be fungistatic. In addition, growth of Candida at sites on mucous membranes may be suppressed by other normal flora. Conditions that predispose to candiduria include diabetes mellitus, antibiotic and corticosteroid therapy, as well as factors such as local physiology and disturbance of urine flow. Lower urinary tract candidiasis is usually the result of a retrograde infection, while renal parenchymal infection most often follows candidemia. In addition to asymptomatic candiduria, recognized clinical forms of candidal urinary tract infections include bladder infection, renal parenchymal infection, and infections associated with fungus ball formation. Unfortunately, clinical criteria alone are insufficient to distinguish reliably among these clinical types. If the urine is found to contain candidal organisms, the condition of the patient should be considered for determination of appropriate therapy. When infection is thought to be confined to the bladder, patients without indwelling bladder catheters should be considered for flucytosine therapy. For patients requiring indwelling bladder catheterization, irrigation with amphotericin B is usually successful. Although flucytosine alone may be useful for renal parenchymal candidal infection, iv amphotericin B alone or the combination of amphotericin B and flucytosine is indicated when systemic candidiasis cannot be excluded.

UR - http://www.scopus.com/inward/record.url?scp=0020210201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020210201&partnerID=8YFLogxK

U2 - 10.1093/clinids/4.6.1107

DO - 10.1093/clinids/4.6.1107

M3 - Article

C2 - 6760338

AN - SCOPUS:0020210201

VL - 4

SP - 1107

EP - 1118

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -